|
CYLANIC
|
-
|
V/DCP/21/0040
|
LIVISTO Int'l, S.L., Spānija
|
QJ01CR02
|
dogs; cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
tablets
|
| International name (active substance): |
Amoxicillin trihydrate, Potassium clavulanate
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
aniMedica GmbH, Vācija;Industrial Veterinaria, S.A., Spānija;Lelypharma B.V., Nīderlande;aniMedica Herstellungs GmbH, Vācija
|
| Date of authorisation/renewal: |
28-Jan-2022
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
DCP
|
| Package leaflet: |
[DOCX] 30062021LI (30-Jun-2021)
|
| Labelling text: |
[DOCX] 30062021M (30-Jun-2021)
|
| Summary of product characteristics: |
[DOCX] 30062021ZA (30-Jun-2021)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/21/0040-01 |
|
1 |
Blisteris, 10 tablete |
-
|
| V/DCP/21/0040-02 |
|
3 |
Blisteris, 10 tablete |
-
|
| V/DCP/21/0040-03 |
|
5 |
Blisteris, 10 tablete |
-
|
| V/DCP/21/0040-04 |
|
10 |
Blisteris, 10 tablete |
-
|
| V/DCP/21/0040-05 |
|
25 |
Blisteris, 10 tablete |
-
|
|
|
CYLANIC
|
-
|
V/DCP/21/0041
|
LIVISTO Int'l, S.L., Spānija
|
QJ01CR02
|
dogs; cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
tablets
|
| International name (active substance): |
Amoxicillin trihydrate, Potassium clavulanate
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Lelypharma B.V., Nīderlande
|
| Date of authorisation/renewal: |
28-Jan-2022
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
DCP
|
| Package leaflet: |
[DOCX] 30062021LI (30-Jun-2021)
|
| Labelling text: |
[DOCX] 30062021M (30-Jun-2021)
|
| Summary of product characteristics: |
[DOCX] 30062021ZA (30-Jun-2021)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/21/0041-01 |
|
1 |
Blisteris, 10 tablete |
-
|
| V/DCP/21/0041-02 |
|
3 |
Blisteris, 10 tablete |
-
|
| V/DCP/21/0041-03 |
|
5 |
Blisteris, 10 tablete |
-
|
| V/DCP/21/0041-04 |
|
10 |
Blisteris, 10 tablete |
-
|
| V/DCP/21/0041-05 |
|
25 |
Blisteris, 10 tablete |
-
|
|
|
CYLANIC
|
-
|
V/DCP/21/0042
|
LIVISTO Int'l, S.L., Spānija
|
QJ01CR02
|
dogs
|
|
Medicinal product information
| Pharmaceutical form: |
tablets
|
| International name (active substance): |
Amoxicillin trihydrate, Potassium clavulanate
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Lelypharma B.V., Nīderlande
|
| Date of authorisation/renewal: |
28-Jan-2022
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
DCP
|
| Package leaflet: |
[DOCX] 30062021LI (30-Jun-2021)
|
| Labelling text: |
[DOCX] 30062021M (30-Jun-2021)
|
| Summary of product characteristics: |
[DOCX] 26042022ZA (26-Apr-2022)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/21/0042-01 |
|
1 |
Blisteris, 10 tablete |
-
|
| V/DCP/21/0042-02 |
|
3 |
Blisteris, 10 tablete |
-
|
| V/DCP/21/0042-03 |
|
5 |
Blisteris, 10 tablete |
-
|
| V/DCP/21/0042-04 |
|
10 |
Blisteris, 10 tablete |
-
|
| V/DCP/21/0042-05 |
|
25 |
Blisteris, 10 tablete |
-
|
|